Page last updated: 2024-10-31

metronidazole and Phlebitis

metronidazole has been researched along with Phlebitis in 1 studies

Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.

Phlebitis: Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).

Research Excerpts

ExcerptRelevanceReference
"Histologic examination confirmed Crohn's disease that was associated with vasculitis and, in particular, with thrombophlebitis and subsequent transmural bowel necrosis."1.32[Pylephlebitis with air in the portal vein system. An unusual focus in a patient with sepsis]. ( Gocht, A; Hahn, KE; Kluge, S; Kreymann, G; Lund, CH, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kluge, S1
Hahn, KE1
Lund, CH1
Gocht, A1
Kreymann, G1

Other Studies

1 other study available for metronidazole and Phlebitis

ArticleYear
[Pylephlebitis with air in the portal vein system. An unusual focus in a patient with sepsis].
    Deutsche medizinische Wochenschrift (1946), 2003, Jun-20, Volume: 128, Issue:25-26

    Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Cefotaxime; Crohn Disease; Diag

2003